Levsin Oral Tablet 0.125Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Levsin: Oral tablet (0.125mg)

Detailed Information
Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Visit Drug Summary Page
Drug Image file DrugItem_13113.JPG
Levsin 0.125mg Tab
Meda Pharmaceuticals, Inc., a division Mylan Specialty L.P.
Pill Identification: AP  |  112
Drug Image file DrugItem_1483.JPG
Anaspaz 0.125mg Tab
BF Ascher and Co Inc
Pill Identification: 225 295  |  A

What is this Medicine?

HYOSCYAMINE (hye oh SYE a meen) is used to treat stomach and bladder problems. It is also used for rhinitis, to reduce some problems caused by Parkinson's disease, and for the treatment of poisoning with drugs that are usually used to treat myasthenia gravis.

CVS Pharmacy Patient Statistics for Levsin: Oral tablet(0.125mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Levsin 0.125mg Tablet

NDC: 682200112
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)




Labeled but not FDA approved for the following conditions:
Irritable Bowel Syndrome, Gastric Ulcer, Duodenal Ulcer

Storage Information
Store between 68 to 77 degrees F, excursions permitted 59 to 86 degrees F
Levsin 0.125mg Tablet
Drug Image file DrugItem_13113.JPG
Meda Pharmaceuticals, Inc., a division Mylan Specialty L.P.
Pill Identification: AP  |  112
Shape: round
Color: blue
Ingredients
Close All Sections Show
Pregnancy & Lactation Information
Close Show
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Levsin

Close Show

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.